If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
35
|
17
|
25
|
1
|
0 |
78
|
Gene and significance breakdown #
Total genes and gene combinations: 53
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
total |
intergenic
|
7
|
2
|
6
|
0 |
15
|
GNB1
|
4
|
0 |
0 |
0 |
4
|
CYFIP1
|
0 |
0 |
2
|
0 |
2
|
DHX30
|
2
|
0 |
0 |
0 |
2
|
GALC
|
0 |
2
|
0 |
0 |
2
|
MED13L
|
2
|
0 |
0 |
0 |
2
|
QARS1
|
0 |
2
|
0 |
0 |
2
|
SLC9A6
|
0 |
1
|
1
|
0 |
2
|
TOGARAM1
|
0 |
0 |
2
|
0 |
2
|
TYR
|
1
|
1
|
0 |
0 |
2
|
ABCG4, ACRV1, ADAMTS15, ADAMTS8, APLP2, APOA1, APOA4, APOA5, APOC3, ARCN1, ARHGAP32, ARHGEF12, ATP5MG, BACE1, BARX2, BCL9L, BLID, BSX, BUD13, C1QTNF5, C2CD2L, CADM1, CBL, CCDC15, CD3D, CD3E, CD3G, CDON, CENATAC, CEP164, CHEK1, CLMP, CRTAM, CXCR5, DCPS, DDX25, DDX6, DPAGT1, DRC12, DSCAML1, EI24, ESAM, ETS1, FAM118B, FEZ1, FLI1, FOXR1, FOXRED1, FXYD2, FXYD6, FXYD6-FXYD2, GRAMD1B, GRIK4, H2AX, HEPACAM, HEPN1, HINFP, HMBS, HSPA8, HYLS1, HYOU1, IFT46, IL10RA, JAML, JHY, KCNJ1, KCNJ5, KIRREL3, KMT2A, LINC02873, LOC101929473, MCAM, MFRP, MIR100, MIR125B1, MIRLET7A2, MPZL2, MPZL3, MSANTD2, NECTIN1, NFRKB, NHERF4, NLRX1, NRGN, NXPE2, NXPE4, OAF, OR10G4, OR10G7, OR10G8, OR10G9, OR10S1, OR4D5, OR6M1, OR6T1, OR6X1, OR8A1, OR8B12, OR8B2, OR8B3, OR8B4, OR8B8, OR8D1, OR8D2, OR8D4, OR8G1, OR8G5, PAFAH1B2, PANX3, PATE1, PATE2, PATE3, PATE4, PCSK7, PHLDB1, PKNOX2, POU2F3, PRDM10, PUS3, RNF214, RNF26, ROBO3, ROBO4, RPS25, RPUSD4, SC5D, SCN2B, SCN3B, SCN4B, SIAE, SIDT2, SIK3, SLC37A2, SLC37A4, SNX19, SORL1, SPA17, SRPRA, ST14, ST3GAL4, STT3A, TAGLN, TBCEL, TBRG1, TECTA, THY1, TIRAP, TLCD5, TMEM218, TMEM225, TMEM25, TMEM45B, TMPRSS13, TMPRSS4, TP53AIP1, TRAPPC4, TREH, TRIM29, TTC36, UBASH3B, UBE4A, UPK2, USP2, VPS11, VSIG2, VWA5A, ZBTB44, ZNF202, ZPR1
|
0 |
1
|
0 |
0 |
1
|
ACVR2A, ARHGAP15, ARL5A, CACNB4, CXCR4, DARS1, EPC2, GTDC1, HNMT, KYNU, LCT, LRP1B, LYPD6, LYPD6B, MBD5, MCM6, MMADHC, NEB, NMI, NXPH2, ORC4, R3HDM1, RBM43, RIF1, RND3, SPOPL, THSD7B, TNFAIP6, UBXN4, ZEB2
|
1
|
0 |
0 |
0 |
1
|
ADGRG1
|
1
|
0 |
0 |
0 |
1
|
AHCTF1
|
0 |
0 |
1
|
0 |
1
|
ALKBH5, ATPAF2, COPS3, DRC3, DRG2, FLCN, FLII, GID4, LLGL1, MED9, MIEF2, MIR33B, MPRIP, MYO15A, NT5M, PEMT, PLD6, RAI1, RASD1, SREBF1, TOM1L2, TOP3A
|
1
|
0 |
0 |
0 |
1
|
ANKRD11
|
1
|
0 |
0 |
0 |
1
|
ASXL3
|
0 |
0 |
1
|
0 |
1
|
ATP10A, GABRA5, GABRB3, GABRG3, GOLGA8M, HERC2, IPW, MAGEL2, MKRN3, NDN, NPAP1, OCA2, PWAR1, PWAR4, PWAR5, PWAR6, PWARSN, PWRN1, PWRN2, SNORD115-1, SNORD116-1, SNRPN, SNURF, UBE3A
|
1
|
0 |
0 |
0 |
1
|
BFSP2
|
1
|
0 |
0 |
0 |
1
|
CACNA1A
|
0 |
1
|
0 |
0 |
1
|
CLUH, METTL16, PAFAH1B1, RAP1GAP2
|
1
|
0 |
0 |
0 |
1
|
COL1A2
|
0 |
0 |
1
|
0 |
1
|
DMBX1
|
0 |
1
|
0 |
0 |
1
|
FASN
|
0 |
0 |
1
|
0 |
1
|
FBN2
|
0 |
0 |
1
|
0 |
1
|
FOXG1
|
1
|
0 |
0 |
0 |
1
|
FOXP1
|
0 |
1
|
0 |
0 |
1
|
GFOD1, MCUR1, NOL7, PHACTR1, RANBP9, RNF182, SIRT5, TBC1D7
|
0 |
0 |
1
|
0 |
1
|
KIF7
|
0 |
1
|
0 |
0 |
1
|
KMT2D
|
1
|
0 |
0 |
0 |
1
|
LMBR1, MNX1, NOM1
|
0 |
0 |
1
|
0 |
1
|
LMBR1, RNF32
|
0 |
0 |
1
|
0 |
1
|
LSM1
|
0 |
0 |
1
|
0 |
1
|
MAFB
|
0 |
0 |
1
|
0 |
1
|
MPP4
|
1
|
0 |
0 |
0 |
1
|
NALCN
|
1
|
0 |
0 |
0 |
1
|
NF1
|
0 |
0 |
1
|
0 |
1
|
NFIX
|
0 |
1
|
0 |
0 |
1
|
NR2F1
|
0 |
0 |
1
|
0 |
1
|
PCDH19
|
1
|
0 |
0 |
0 |
1
|
POGZ
|
1
|
0 |
0 |
0 |
1
|
PTPN11
|
1
|
0 |
0 |
0 |
1
|
RSRC2
|
0 |
1
|
0 |
0 |
1
|
SIL1
|
1
|
0 |
0 |
0 |
1
|
SLC2A1
|
1
|
0 |
0 |
0 |
1
|
SMARCA4
|
0 |
0 |
0 |
1
|
1
|
SOX3
|
0 |
0 |
1
|
0 |
1
|
SOX5
|
0 |
1
|
0 |
0 |
1
|
SPART
|
0 |
1
|
0 |
0 |
1
|
STXBP1
|
1
|
0 |
0 |
0 |
1
|
TFAP2A
|
1
|
0 |
0 |
0 |
1
|
TMCO1
|
1
|
0 |
0 |
0 |
1
|
TUBB4A
|
0 |
0 |
1
|
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
total |
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
9
|
7
|
7
|
1
|
24
|
Talkowski Laboratory, Center for Human Genetic Research, Massachusetts General Hospital
|
7
|
2
|
6
|
0 |
15
|
Center for Personalized Medicine, Children's Hospital Los Angeles
|
1
|
3
|
2
|
0 |
6
|
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
|
4
|
1
|
0 |
0 |
5
|
NIHR Bioresource Rare Diseases, University of Cambridge
|
3
|
1
|
0 |
0 |
4
|
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
|
0 |
0 |
4
|
0 |
4
|
Genomics And Bioinformatics Analysis Resource, Columbia University
|
4
|
0 |
0 |
0 |
4
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
|
0 |
0 |
3
|
0 |
3
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
|
0 |
2
|
0 |
0 |
2
|
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
|
2
|
0 |
0 |
0 |
2
|
Institute for Human Genetics and Genomic Medicine, Uniklinik RWTH Aachen
|
0 |
0 |
1
|
0 |
1
|
Agency for Science, Technology and Research, Genome Institute of Singapore
|
1
|
0 |
0 |
0 |
1
|
Erez Levanon lab, Bar Ilan University
|
1
|
0 |
0 |
0 |
1
|
Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences
|
0 |
1
|
0 |
0 |
1
|
Human Molecular Genetics and Metabolic Disorders, Pakistan Institute for Engineering and Applied Science (PIEAS)
|
1
|
0 |
0 |
0 |
1
|
Wendy Chung Laboratory, Columbia University Medical Center
|
0 |
0 |
1
|
0 |
1
|
Clinical Genetics, Amsterdam Medical Centre
|
0 |
0 |
1
|
0 |
1
|
Medical Genetics Laboratory, CHRU Nancy
|
1
|
0 |
0 |
0 |
1
|
DASA
|
1
|
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.